Novel treatment for triple negative breast cancer using Poloxamer
Project/Area Number |
23591912
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
General surgery
|
Research Institution | Kurume University |
Principal Investigator |
|
Project Period (FY) |
2011-04-28 – 2015-03-31
|
Project Status |
Completed (Fiscal Year 2014)
|
Budget Amount *help |
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2013: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2012: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2011: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
Keywords | 癌ナノテクノロジー / トリプルネガティブ乳癌 / ミセルナノ粒子 / 乳癌 |
Outline of Final Research Achievements |
Poloxamer was toxic to triple negative human breast cancer cells MDA-MB-231 in culture as evidenced by propidium iodide assays compared with human mammary epithelial (non-cancer) cells MCF12A. Poloxamer had significant cytotoxicity against MDA-MB-231 than MCF12A by the LDH assay. Poloxamer was not associated with cell proliferation in both MDA-MB-231 and MCF12A. oPloxamer inhibited the growth of breast cancer tumors in intravenous administration. However, Ploxamer did not inhibit the growth of breast cancer tumors in the oral administration.
|
Report
(5 results)
Research Products
(12 results)
-
[Journal Article] HER2-targeted Therapeutic Strategies for HER2-positive Metastatic Breast Cancers2014
Author(s)
Teruhiko Fujii, Keisuke Miwa, Tomoyuki Ushijima, Mototsugu Matsunaga, Masaru Fukahori, Kotaro Yuge, Uhi Toh, Nobutaka Iwakuma, Ryuji Takahashi, Hiroki Takahashi, Miki Takenaka, Mai Mishima, Yoshito Akagi, Masayoshi Kage , Shino Nakagawa
-
Journal Title
Current Cancer Therapy Reviews
Volume: 10
Issue: 3
Pages: 225-233
DOI
Related Report
Peer Reviewed / Open Access
-
-
[Journal Article] FOXP3 expression in tumor cells and tumor-infiltrating lymphocytes is associated with breast cancer prognosis2013
Author(s)
Miki Takenaka, Naoko Seki, Uhi Toh, Satoshi Hattori, Akihiko Kawahara, Tomohiko Yamaguchi, Keiko Koura, Ryuji Takahashi, Hiroko Otsuka, Hiroki Takahashi, Nobutaka Iwakuma, Shino Nakagawa, Teruhiko Fujii, Tetsuro Sasada, Rin Yamaguchi, Hirohisa Yano, Kazuo Shirouzu, Masayoshi Kage
-
Journal Title
Molecular and Clinical Oncology
Volume: 1
Issue: 4
Pages: 625-632
DOI
Related Report
Peer Reviewed
-
-
-
-
-
-
-
-
-